ATAGI recommendations on the use of a third primary dose of COVID-19 vaccine in individuals who are severely immunocompromised

Downloads

ATAGI recommendations on the use of a third primary dose of COVID-19 vaccine in individuals who are severely immunocompromised

We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

Publication date: 
8 October 2021
Publication type: 
Guideline
Intended audience: 
General public